Sign Out
Rosuvastatin is contraindicated in pregnancy and lactation.
Pregnancy: There are no adequate and well controlled studies using statins in pregnant women and there is no known clinical benefit for continued use during pregnancy. Because statins including rosuvastatin may cause fetal harm when administered to pregnant women. Therefore, rosuvastatin is contraindicated in women who are or may become pregnant. If the patient becomes pregnant while receiving the drug, it should be discontinued immediately and the patient informed of the potential fetal hazard and the lack of known clinical benefit with continued use during pregnancy.
Lactation: Rosuvastatin is excreted into milk in rats. It is not known whether rosuvastatin is distributed into human milk. However, the drug is contraindicated in nursing women because of the potential for serious adverse reactions in nursing infants. Women who require rosuvastatin therapy should not breast-feed their infants.
